Accelerating Research and Development in NSW
Policy & Practice Report
Clinical and community trial
About the study
Chronic Obstructive Pulmonary Disease (COPD) is the third-leading cause of global health-related disease and deaths. Heart disease is very common in people diagnosed with COPD and is often the cause of health-related sickness and hospitalisations, causing 30 – 50% of deaths. Studies repeatedly show that heart disease is often not diagnosed in persons with COPD, and when it is diagnosed it is often under-treated. People with COPD are also commonly not included in clinical trials of drugs which treat heart disease and heart-related deaths.
Beta (β)-blockers are medications often used to treat heart disease. In this study, we will be investigating whether pro-active treatment with a β-blocker in people with COPD can reduce heart-related events, such as strokes and heart attacks. This is important for people with COPD with either known or unknown underlying heart disease. The study also aims to investigate whether this treatment influences number of respiratory flare ups (exace
Clinical and community trial
About this study
Australians are increasingly shopping online for their groceries however we don’t have much evidence on the level of influence of information available to consumers online. The aim of this research is to understand how online grocery purchasing choices may change depending on the information being presented online.
Recruitment criteria
Aged 18-75
Have high blood pressure
Diagnosed by your doctor or currently taking a stable dose of blood pressure lowering medications
Regularly purchase most of their groceries online from Woolworths and plan to continue for the duration of the study (4 months) or for those who don’t currently shop with Woolworths, you will also be eligible if you switch to shopping at Woolworths for the duration of the study
Would be willing to shop for their groceries online for the study
What’s involved?
Participants will be asked to complete the following research activities if they consent to join t
The George Institute's pre-budget submission 2023 – 2024
Policy & Practice Report
Centre of Research Excellence: Healthy Food, Healthy Planet, Healthy People
Millions of Australians and hundreds of millions of people around the world suffer from conditions caused by excessive consumption of unhealthy foods and insufficient intake of healthy foods. The food system is one of the largest contributors to environmental degradation through greenhouse gas emissions, water use and deforestation, and one of the sectors hardest hit by climate change. Access to information about the nutritional quality and environmental impacts of the food we eat is a basic consumer right, yet is lacking.
The Healthy Food, Healthy Planet, Healthy People Centre for Research Excellence will deliver world-leading innovations in nutrient profiling algorithms and environmental indicators that estimate the human and planetary consequences of varying patterns of food and beverage consumption.
The project will: Identify effective means of conveying combined nutrition and sustainability information. Use the developed algorithms, environmental indicators and user response data
ACT-GLOBAL: A multi-faCtorial, mulTi-arm, multi-staGe, randomised, gLOBal Adaptive pLatform trial for stroke
Background
Stroke remains a leading cause of death and disability worldwide. Despite advances in medical technology and treatment strategies, many patients still do not achieve optimal outcomes. The George Institute’s ACT-GLOBAL study is an adaptive platform trial that is aiming to address the urgent need for the development of new and more effective interventions for stroke patients across the world.
A platform trial involves study of several different clinical questions at the same time, essentially uniting multiple clinical trials or ‘Domains’ under a single organisational structure lead by experts in the field. Adaptive design allows the team to add or collapse (if needed) research questions during the trial as more information is collected. We believe the adaptive platform approach is a uniquely flexible and efficient way to conduct ground-breaking research.
The ACT-GLOBAL platform currently has several domains across the stroke-subtypes of Acute Ischemic Stroke, where a bloc
Intensive blood glucose management in intensive care patients
Policy & Practice Report
Recommendations for new blood pressure treatments
Policy & Practice Report
Saline or Albumin for fluid resuscitation in patients with traumatic brain injury
Policy & Practice Report
Vascular disease prevention in Australia
Policy & Practice Report
Australian Government National Health And Hospital Reform Commission
Policy & Practice Report
Australian Government Preventative Health Taskforce: Towards a National Primary Health Care Strategy
Policy & Practice Report